UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 183

Sortiert nach

Complications and Predictive Factors for Air Leak > 10 Days with Neoadjuvant Chemotherapy Followed by Pleurectomy/Decortication for Malignant Pleural Mesothelioma

Annals of surgical oncology, 2021-06, Vol.28 (6), p.3057-3065

2021

Volltextzugriff (PDF)

Epigenetic Alterations and Biomarkers for Immune Checkpoint Inhibitors-Current Standards and Future Perspectives in Malignant Pleural Mesothelioma Treatment

Frontiers in oncology, 2020-12, Vol.10, p.554570-554570

2020

Volltextzugriff (PDF)

Circulating Tumor Cell as a Diagnostic Marker in Primary Lung Cancer

Clinical cancer research, 2009-11, Vol.15 (22), p.6980-6986

2009

Volltextzugriff (PDF)

Tumor‐associated macrophage‐derived inflammatory cytokine enhances malignant potential of malignant pleural mesothelioma

Cancer science, 2020-08, Vol.111 (8), p.2895-2906

2020

Volltextzugriff (PDF)

Present and future roles of FDG-PET/CT imaging in the management of malignant pleural mesothelioma

Japanese Journal of Radiology, 2016-08, Vol.34 (8), p.537-547

2016

Volltextzugriff (PDF)

Radiation Pneumonitis After Volumetric Modulated Arc Therapy for Non-small Cell Lung Cancer

Anticancer research, 2021-11, Vol.41 (11), p.5793-5802

2021

Volltextzugriff (PDF)

Utility of polaprezinc in reducing toxicities during radiotherapy: a literature review

Future oncology (London, England), 2018-08, Vol.14 (19), p.1977-1988

2018

Volltextzugriff (PDF)

Types of surgery post-neoadjuvant chemotherapy for pleural mesothelioma

Expert review of respiratory medicine, 2019-12, Vol.13 (12), p.1189-1194

2019

Volltextzugriff (PDF)

Initial evaluation of nivolumab in patients with post-operative recurrence of malignant pleural mesothelioma

Japanese journal of clinical oncology, 2020-08, Vol.50 (8), p.920-925

2020

Volltextzugriff (PDF)

EphA2 inhibition suppresses proliferation of small-cell lung cancer cells through inducing cell cycle arrest

Biochemical and biophysical research communications, 2019-11, Vol.519 (4), p.846-853

2019

Volltextzugriff (PDF)

Efficacy and safety of nivolumab with ipilimumab for recurrent malignant pleural mesothelioma after primary surgical intervention

International journal of clinical oncology, 2023-03, Vol.28 (3), p.409-415

2023

Volltextzugriff (PDF)

Adenosine Deaminase Inhibitor EHNA Exhibits a Potent Anticancer Effect Against Malignant Pleural Mesothelioma

Cellular physiology and biochemistry, 2015-01, Vol.35 (1), p.51-60

2015

Volltextzugriff (PDF)

Response to Immune Checkpoint Inhibitor Therapy in Patients with Unresectable Recurrent Malignant Pleural Mesothelioma Shown by FDG-PET and CT

Cancers, 2021-03, Vol.13 (5), p.1098

2021

Volltextzugriff (PDF)

Analysis of Pleiotropic Effects of Nivolumab in Pretreated Advanced or Recurrent Non-small Cell Lung Cancer Cases

In vivo (Athens), 2019-03, Vol.33 (2), p.507-514

2019

Volltextzugriff (PDF)

Sarcomatoid malignant pleural mesothelioma associated with anti-Ma2-related paraneoplastic neurological syndrome: A case report

Current problems in cancer. Case reports, 2023-09, Vol.11, p.100244, Article 100244

2023

Volltextzugriff (PDF)

Present and future roles of FDG-PET/CT imaging in the management of lung cancer

Japanese Journal of Radiology, 2016-06, Vol.34 (6), p.387-399

2016

Volltextzugriff (PDF)

Circulating Tumor Cells (CTCs) in Malignant Pleural Mesothelioma (MPM)

Annals of surgical oncology, 2014-12, Vol.21 (Suppl 4), p.472-480

2014

Volltextzugriff (PDF)

A superior vena cava aneurysm discovered by chance at regular physical examination

Respiratory investigation, 2020-07, Vol.58 (4), p.291-294

2020

Volltextzugriff (PDF)

Early-stage Clinical Characterization of Malignant Pleural Mesothelioma

In vivo (Athens), 2018-09, Vol.32 (5), p.1169-1174

2018

Volltextzugriff (PDF)

Clinical Significance of Serum Vascular Endothelial Growth Factor in Malignant Pleural Mesothelioma

Journal of thoracic oncology, 2010-04, Vol.5 (4), p.479-483

2010

Volltextzugriff (PDF)

Do we still need to debate the merits of pleurectomy/decortication vs. extrapleural pneumonectomy for malignant pleural mesothelioma?

Translational lung cancer research, 2023-02, Vol.12 (2), p.193-196

2023

Volltextzugriff (PDF)

Usefulness of Quantitative Bone Single-Photon Emission Computed Tomography/Computed Tomography for Evaluating the Treatment Response of Bone Metastasis in a Lung Cancer Patient

Case reports in oncology, 2021-01, Vol.14 (1), p.391-396

2021

Volltextzugriff (PDF)

Pemetrexed for epithelioid haemangioendothelioma of the pleura

Respirology case reports, 2016-11, Vol.4 (6), p.e00191-n/a

2016

Volltextzugriff (PDF)

Successful Treatment of Pulmonary Pleomorphic Carcinoma with Nivolumab: A Case Report

Case reports in oncology, 2018-05, Vol.11 (2), p.336-340

2018

Volltextzugriff (PDF)

Circulating Endothelial Cell (CEC) as a Diagnostic and Prognostic Marker in Malignant Pleural Mesothelioma (MPM)

Annals of surgical oncology, 2012-12, Vol.19 (13), p.4229-4237

2012

Volltextzugriff (PDF)

1 – 25 von 183

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(136)
Mit Volltextzugriff
(161)

Publikationsform

Sprache

Englisch
(153)
Japanisch
(62)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Complications and Predictive Factors for Air Leak > 10 Days with Neoadjuvant Chemotherapy Followed by Pleurectomy/Decortication for Malignant Pleural Mesothelioma

Epigenetic Alterations and Biomarkers for Immune Checkpoint Inhibitors-Current Standards and Future Perspectives in Malignant Pleural Mesothelioma Treatment

Circulating Tumor Cell as a Diagnostic Marker in Primary Lung Cancer

Tumor‐associated macrophage‐derived inflammatory cytokine enhances malignant potential of malignant pleural mesothelioma

Present and future roles of FDG-PET/CT imaging in the management of malignant pleural mesothelioma

Radiation Pneumonitis After Volumetric Modulated Arc Therapy for Non-small Cell Lung Cancer

Utility of polaprezinc in reducing toxicities during radiotherapy: a literature review

Types of surgery post-neoadjuvant chemotherapy for pleural mesothelioma

Initial evaluation of nivolumab in patients with post-operative recurrence of malignant pleural mesothelioma

EphA2 inhibition suppresses proliferation of small-cell lung cancer cells through inducing cell cycle arrest

Efficacy and safety of nivolumab with ipilimumab for recurrent malignant pleural mesothelioma after primary surgical intervention

Adenosine Deaminase Inhibitor EHNA Exhibits a Potent Anticancer Effect Against Malignant Pleural Mesothelioma

Response to Immune Checkpoint Inhibitor Therapy in Patients with Unresectable Recurrent Malignant Pleural Mesothelioma Shown by FDG-PET and CT

Analysis of Pleiotropic Effects of Nivolumab in Pretreated Advanced or Recurrent Non-small Cell Lung Cancer Cases

Sarcomatoid malignant pleural mesothelioma associated with anti-Ma2-related paraneoplastic neurological syndrome: A case report

Present and future roles of FDG-PET/CT imaging in the management of lung cancer

Circulating Tumor Cells (CTCs) in Malignant Pleural Mesothelioma (MPM)

A superior vena cava aneurysm discovered by chance at regular physical examination

Early-stage Clinical Characterization of Malignant Pleural Mesothelioma

Clinical Significance of Serum Vascular Endothelial Growth Factor in Malignant Pleural Mesothelioma

Do we still need to debate the merits of pleurectomy/decortication vs. extrapleural pneumonectomy for malignant pleural mesothelioma?

Usefulness of Quantitative Bone Single-Photon Emission Computed Tomography/Computed Tomography for Evaluating the Treatment Response of Bone Metastasis in a Lung Cancer Patient

Pemetrexed for epithelioid haemangioendothelioma of the pleura

Successful Treatment of Pulmonary Pleomorphic Carcinoma with Nivolumab: A Case Report

Circulating Endothelial Cell (CEC) as a Diagnostic and Prognostic Marker in Malignant Pleural Mesothelioma (MPM)

Suchergebnisse filtern